Association between 21-gene-assay and detection of disseminated tumor cells in patients with early breast cancer: results from the IRMA trial

PURPOSE: Disseminated tumor cells (DTCs) in the bone marrow (BM) are known to be of prognostic value for patients with early breast cancer (EBC). In addition to histopathological features, multigene expression assays, such as the commercially available 21-gene Breast Recurrence Score® assay, have be...

Descripción completa

Detalles Bibliográficos
Autores principales: Volmer, Léa L., Dannehl, Dominik, Engler, Tobias, Hahn, Markus, Walter, Christina B., Wallwiener, Markus, Brucker, Sara Y., Taran, Florin-Andrei, Hartkopf, Andreas D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504215/
https://www.ncbi.nlm.nih.gov/pubmed/37556015
http://dx.doi.org/10.1007/s10549-023-07031-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504215/
https://www.ncbi.nlm.nih.gov/pubmed/37556015
http://dx.doi.org/10.1007/s10549-023-07031-w

Ejemplares similares